Print this page

Merck Consolidated Statement of Changes in Net Equity 

For details see Note [50]

XLS

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity capital

 

Retained earnings

Gains/losses recognized in equity

 

 

 

€ million

General partner’s equity Merck KGaA

Sub­scribed capital Merck KGaA

Capital reserves (share premium) Merck KGaA

Re­tained ear­nings/
Net retained profit

Re­measure­ment of defined benefit plans

Available-for-sale financial assets

Deri­vative financial in­stru­ments

Curr­ency trans­lation diff­erence

Equity attri­butable to Merck KGaA share­holders

Non-
controlling interests

Total equity

Balance as of January 1, 2012

397.2

168.0

3,813.7

5,237.1

–378.2

0.8

–94.6

1,304.0

10,448.0

46.3

10,494.3

Profit after tax

566.7

566.7

12.3

579.0

Other comprehensive income

–266.7

0.4

65.1

–31.8

–233.0

–3.2

–236.2

Comprehensive income

566.7

–266.7

0.4

65.1

–31.8

333.7

9.1

342.8

Dividend payments

–96.9

–96.9

–5.7

–102.6

Profit transfers to/from E. Merck KG including changes in reserves

–304.5

–304.5

–304.5

Transactions with no change of control

–15.3

–15.3

0.3

–15.0

Changes in scope of consolidation/Other

–3.2

–0.4

–3.6

3.4

–0.2

Balance as of December 31, 2012

397.2

168.0

3,813.7

5,383.9

–645.3

1.2

–29.5

1,272.2

10,361.4

53.4

10,414.8

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of January 1, 2013

397.2

168.0

3,813.7

5,383.9

–645.3

1.2

–29.5

1,272.2

10,361.4

53.4

10,414.8

Profit after tax

1,202.2

1,202.2

6.9

1,209.1

Other comprehensive income

82.6

–0.2

73.7

–203.7

–47.6

–10.2

–57.8

Comprehensive income

1,202.2

82.6

–0.2

73.7

–203.7

1,154.6

–3.3

1,151.3

Dividend payments

–109.9

–109.9

–3.7

–113.6

Profit transfers to/from E. Merck KG including changes in reserves

–383.0

–383.0

–383.0

Transactions with no change of control

–3.1

–3.1

2.8

–0.3

Changes in scope of consolidation/Other

Balance as of December 31, 2013

397.2

168.0

3,813.7

6,090.1

–562.7

1.0

44.2

1,068.5

11,020.0

49.2

11,069.2

© Merck KGaA, Darmstadt, Germany, Last Update 2014/03/06